Hematologic Cancer
Conditions
Interventions
None listed
Sponsors
Kurume University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients hospitalized for chemotherapy for hematologic cancer who underwent rehabilitation.
Exclusion criteria
Exclusion criteria: 25-question Geriatric Locomotive Function Scale not performed Hematologic diseases such as aplastic anemia, autoimmune thrombocytopenia, and myelodysplastic syndromes, which undergo chemotherapy similar to that for hematologic cancers Patients with consciousness disturbance (JCS I-1 or higher) at the time of admission Patients with dementia requiring care in daily life (activities of daily living independence level III or higher for elderly individuals with dementia) Patients with a history of central nervous system disorders with clear clinical symptoms such as paralysis or sensory disturbances Patients with a history of peripheral nerve disorders with clear clinical symptoms such as paralysis or sensory disturbances
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Performance Status, Locomotive Syndrome (25-question Geriatric Locomotive Function Scale), Sarcopenia, Activities of Daily Living Independence Level | — |
Secondary
| Measure | Time frame |
|---|---|
| Physical function (grip strength, walking speed, chair rise time (SPPB), balance function, calf circumference) Nutritional indicators (GNRI, PNI, CONUT, modified CONUT) Inflammatory markers (CRP) Comorbidities Coexisting diseases Prognosis | — |
Countries
Japan
Contacts
Public ContactHiroo Matsuse
Kurume University Rehabilitation center
Outcome results
None listed